IB Australian Bioscience Fund I, managed by Octa Phillip Bioscience Managers (OPBM, formerly IB Managers) has today entered into a conditional Subscription Agreement to invest NZD$2.5 million into Claridge Capital (NZX.CLA) in conjunction with Claridge’s acquisition of SeaDragon Marine Oils. The subscription arrangement is conditional upon the satisfaction of a number of commercial conditions. The […]
/wp-content/uploads/2018/01/BSM_logo.png00keymaster/wp-content/uploads/2018/01/BSM_logo.pngkeymaster2012-09-11 17:40:302019-02-13 12:39:58Australian Bioscience Fund I to invest in Sea Dragon Marine Oils
Octa Phillip Bioscience Managers provision of management services and support to Union MedTech Plc, the UK listed medical technology investment vehicle, today received a boost with Union Medtech’s announcement of the appointment of Dr William (Bill) Hunter to its board. William Hunter co-founded Angiotech Pharmaceuticals in 1992 while still being a medical student at university. […]
/wp-content/uploads/2018/01/BSM_logo.png00keymaster/wp-content/uploads/2018/01/BSM_logo.pngkeymaster2012-07-16 17:29:402018-01-06 17:30:47Angiotech Founder Joins Union Medtech & Bioscience Managers’ Global Team
New look Octa Phillip Bioscience Managers (Bioscience Managers – formerly IB Managers) is looking to create an all-star team with the addition of Starmine top rated analyst Dr Graeme Wald as it progresses towards a first close on its second fund. With its first fund’s performance confirmed in the top decile of global (2008 ex-US) […]
/wp-content/uploads/2018/01/BSM_logo.png00keymaster/wp-content/uploads/2018/01/BSM_logo.pngkeymaster2012-05-11 17:31:212018-01-06 17:31:44Leading Fund Manager Snares Star Analyst
Australian Bioscience Fund I to invest in Sea Dragon Marine Oils
/in BioSciences Managers, SeaDragonIB Australian Bioscience Fund I, managed by Octa Phillip Bioscience Managers (OPBM, formerly IB Managers) has today entered into a conditional Subscription Agreement to invest NZD$2.5 million into Claridge Capital (NZX.CLA) in conjunction with Claridge’s acquisition of SeaDragon Marine Oils. The subscription arrangement is conditional upon the satisfaction of a number of commercial conditions. The […]
Angiotech Founder Joins Union Medtech & Bioscience Managers’ Global Team
/in BioSciences ManagersOcta Phillip Bioscience Managers provision of management services and support to Union MedTech Plc, the UK listed medical technology investment vehicle, today received a boost with Union Medtech’s announcement of the appointment of Dr William (Bill) Hunter to its board. William Hunter co-founded Angiotech Pharmaceuticals in 1992 while still being a medical student at university. […]
Leading Fund Manager Snares Star Analyst
/in BioSciences ManagersNew look Octa Phillip Bioscience Managers (Bioscience Managers – formerly IB Managers) is looking to create an all-star team with the addition of Starmine top rated analyst Dr Graeme Wald as it progresses towards a first close on its second fund. With its first fund’s performance confirmed in the top decile of global (2008 ex-US) […]